评估分层T-SPOT.TB结果对结核病诊断准确性的价值:一项回顾性队列研究及其灵敏度、特异度和预测值
该回顾性队列研究纳入2010至2017年在奥胡斯大学医院连续接受T-SPOT.TB检测的患者,随访至2022年。8542例完整随访者中59例发生 incident TBD,9014例单次检测者中162例为 prevalent TBD。斑点数越高 incident TBD 风险越高,超过10个斑点后趋于平台;临界和阳性结果与 TBD 风险强相关。
要点
- 与阴性结果(≤4个斑点)相比,临界(5-7个斑点)和阳性(≥8个斑点)的 incident TBD 调整风险比分别为5.0和8.0。
- 临界和阳性结果的 prevalent TBD 调整风险比分别为14.9和35.6。
- incident 和 prevalent TBD 的灵敏度分别为54.0%和78.4%,特异度分别为84.8和83.7。
核心结论
- incident TBD 风险随 T-SPOT.TB 值升高而增加,但超过10个斑点后趋于平台。
- 临界和阳性 T-SPOT.TB 结果与 TBD 风险强相关。
研究设计与样本
- 回顾性队列研究,纳入2010至2017年在奥胡斯大学医院连续接受T-SPOT.TB检测的患者,随访 incident TBD 至2022年。
- 8542例完整随访者中59例发生 incident TBD,随访共67 456人年;9014例单次检测者中162例为 prevalent TBD。
- 采用限制性立方样条 Cox 比例风险模型评估定量斑点计数与 incident TBD 风险的关系,Cox 和 log-binomial 回归识别危险因素。
- T-SPOT.TB 为指数试验,微生物学和/或临床确诊的 TBD 为参考标准,评估灵敏度、特异度和预测值。
主要发现
- 与阴性结果(≤4个斑点)相比,incident TBD 的调整风险比:临界(5-7个斑点)为5.0(95% CI: 1.9-13.1),阳性(≥8个斑点)为8.0(95% CI: 4.0-15.7)。
- 与阴性结果(≤4个斑点)相比,prevalent TBD 的调整风险比:临界(5-7个斑点)为14.9(95% CI: 7.7-28.9),阳性(≥8个斑点)为35.6(95% CI: 21.4-59.2)。
- incident TBD 的灵敏度为54.0%(95% CI: 39.3-68.2%),特异度为84.8(95% CI: 84.0-85.4)。
- prevalent TBD 的灵敏度为78.4%(95% CI: 71.3-84.5%),特异度为83.7(95% CI: 82.9-84.4)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The study aimed to investigate the association between quantitative T-SPOT.TB values and the risk of incident and prevalent tuberculosis disease (TBD), identify risk factors, and evaluate test accuracy. METHODS: This retrospective cohort study followed patients tested consecutively with T-SPOT.TB at Aarhus University Hospital from 2010 to 2017, with follow-up for incident TBD through 2022. Data on demographics, comorbidities, medications, and TB status were collected from patient records and national registries. Cox proportional hazard models with restricted cubic splines assessed the risk of incident TBD (occurring ≥3 months post-test) by quantitative spot counts. Cox and log-binomial regressions identified risk factors for incident and prevalent TBD (occurring between 3 months before and after the test). Sensitivity, specificity, and predictive values assessed test accuracy. T-SPOT.TB was the index test, and microbiologically and/or clinically confirmed TBD was the reference standard. RESULTS: Among 8542 individuals with complete follow-up, 59 developed incident TBD over 67 456 person-years. Among 9014 individuals tested once, 162 had prevalent TBD at the time of testing. The risk of incident TBD increased with higher spot counts, plateauing for tests with more than ten spots. The strongest risk factors for both incident and prevalent TBD were categorical T-SPOT.TB results: compared with negative tests (≤4 spots), adjusted hazard ratios for incident TBD were 5.0 (95% CI: 1.9-13.1) for borderline (5-7 spots) and 8.0 (95% CI: 4.0-15.7) for positive tests (≥8 spots). Adjusted risk ratios for prevalent TBD were 14.9 (95% CI: 7.7-28.9) for borderline and 35.6 (95% CI: 21.4-59.2) for positive tests. Sensitivities for incident and prevalent TBD were 54.0% (95% CI: 39.3-68.2%) and 78.4% (95% CI: 71.3-84.5%), respectively. Specificities were 84.8 (84.0-85.4) and 83.7 (82.9-84.4), respectively. DISCUSSION: Incident TBD risk increases with T-SPOT.TB values but plateaus beyond 10 spots. Borderline and positive T-SPOT.TB results are strongly linked to TBD risk.
引用
- Skouvig Pedersen O, Sperling S, Koch A, et al. Evaluating stratified T-SPOT.TB results for diagnostic accuracy in tuberculosis disease: a retrospective cohort study with sensitivities, specificities, and predictive values. Clin Microbiol Infect. 2025. PMID: 39793964. doi:10.1016/j.cmi.2025.01.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。